Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21608528rdf:typepubmed:Citationlld:pubmed
pubmed-article:21608528lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:21608528lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21608528lifeskim:mentionsumls-concept:C0031727lld:lifeskim
pubmed-article:21608528lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:21608528lifeskim:mentionsumls-concept:C1880355lld:lifeskim
pubmed-article:21608528pubmed:issue12lld:pubmed
pubmed-article:21608528pubmed:dateCreated2011-6-16lld:pubmed
pubmed-article:21608528pubmed:abstractTextc-Met is a transmembrane tyrosine kinase that mediates activation of several signaling pathways implicated in aggressive cancer phenotypes. In recent years, research into this area has highlighted c-Met as an attractive cancer drug target, triggering a number of approaches to disrupt aberrant c-Met signaling. Screening efforts identified a unique class of 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one kinase inhibitors, exemplified by 1. Subsequent SAR studies led to the development of 81 (MK-2461), a potent inhibitor of c-Met that was efficacious in preclinical animal models of tumor suppression. In addition, biochemical studies and X-ray analysis have revealed that this unique class of kinase inhibitors binds preferentially to the activated (phosphorylated) form of the kinase. This report details the development of 81 and provides a description of its unique biochemical properties.lld:pubmed
pubmed-article:21608528pubmed:languageenglld:pubmed
pubmed-article:21608528pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:citationSubsetIMlld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21608528pubmed:statusMEDLINElld:pubmed
pubmed-article:21608528pubmed:monthJunlld:pubmed
pubmed-article:21608528pubmed:issn1520-4804lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:YenPPlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:LumbKevin JKJlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:MarshallC...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:KuniiKaikoKlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:SzewczakAlexa...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:QuXianluXlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:GuerinDavid...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:LimJongwonJlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:DinsmoreChris...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:HatchHaroldHlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:KatzJason DJDlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:ReillyJohn...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:WangWenxianWlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:DahlbergWilli...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:LutterbachBar...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:PatelSangita...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:WalkerDeborah...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:JewellJames...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:GabardaAna...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:DeshmukhSujal...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:RickertKeith...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:SoissonStephe...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:DavisLenoraLlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:YoungJonathan...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:PanBo-ShengBSlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:NazefNaimNlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:MathvinkRober...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:HangGaozhenGlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:ZengQinwenQlld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:RosensteinCra...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:AltmanMichael...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:FalconeDaniel...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:HolmesRachael...lld:pubmed
pubmed-article:21608528pubmed:authorpubmed-author:SpencerKerrie...lld:pubmed
pubmed-article:21608528pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21608528pubmed:day23lld:pubmed
pubmed-article:21608528pubmed:volume54lld:pubmed
pubmed-article:21608528pubmed:ownerNLMlld:pubmed
pubmed-article:21608528pubmed:authorsCompleteYlld:pubmed
pubmed-article:21608528pubmed:pagination4092-108lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:meshHeadingpubmed-meshheading:21608528...lld:pubmed
pubmed-article:21608528pubmed:year2011lld:pubmed
pubmed-article:21608528pubmed:articleTitleDiscovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer.lld:pubmed
pubmed-article:21608528pubmed:affiliationDepartment of Chemistry, Merck Research Laboratories, 33 Avenue Louis Pasteur, BMB-2-114, Boston, Massachusetts 02115, United States. jason_katz2@merck.comlld:pubmed
pubmed-article:21608528pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:21608528lld:chembl